|
|
 Purchase CD >> Molecular Diagnostics World CongressA Simple Algorithm for Assessing Overall and Specific Impact of Diagnostic-Type Tests on Medicines Development and Marketing
Eddie Blair, Managing Director, Integrated Medicines
EGFR Mutation Detection and SNP Genotyping in 30 minutes; A Novel, New Molecular Diagnostic Technology
Paul Cizdziel, Senior Scientist, RIKEN Yokohama Institute
Beyond Amplification: Use of Direct Linear Analysis to Diagnose Human Infectious Diseases
Carolyn Conant, Staff Scientist, U.S. Genomics
Twelve Protein Biomarkers in Blood Serum for Early Detection and Determination of Disease Severity of Patients with Breast Cancer
Ira Goldknopf, Director of Proteomics, Power3Medical Products
Development of a Multi-Gene Test for the Early Assessment of Susceptibility to Autism
Jorg Hager, CSO, IntegraGen
Multi Center Validation of a New Molecular Diagnostic Assay for Accurate and Rapid Screening of JAK2 V617F Mutation
Fabienne Hermitte, CSO, Ipsogen
Keynote Address - Innovative Molecular Diagnostics for Personalized Medicine
K.K. Jain, CEO, Jain Pharmabiotech
Use of Microtranponders in Fluidics-Based DNA Assays
Wlodek Mandecki, President, PharmaSeq
Production and QC of Oligonucleotides for use in Clinical Diagnostic Applications
Trey Martin, COO, Integrated DNA Technologies
Licensing Issues in Molecular Diagnostics
Robert Morrison, Managing Director, Bioinvension
4-plex Three-Locus Real-Time PCR Assays for Methicillin-Resistant Staphylococcus Aureus (MRSA)
Yosef Paitan, Scientific Advisor, Syntezza
Keynote Address - Distinguishing Adenoma from Carcinoma in Thyroid Cancers
Gregory Riggins, Associate Professor, Johns Hopkins University School of Medicine
Targeted Metabolomics - Use Cases and Visions for Molecular Diagnostics
Klaus Weinberger, CSO, BIOCRATES Life Sciences Cancer Proteomics World Congres Proteomics: An Enabling Technology for Individualized Therapy
Virginia Espina, Research Assistant Professor, George Mason University
Keynote Address - Validation of Protein Biomarkers in Tissue Arrays
William Gallagher, Associate Professor of Cancer Biology, University College Dublin
Forty Seven Protein Biomarkers in Blood Serum for Early Detection, Differential Diagnosis, and Monitoring of Disease Severity of Patients with Neurodegenerative Diseases
Ira Goldknopf, Director of Proteomics, Power3Medical Products
Keynote Address - Role of Oncoproteomics in Personalized Management of Cancer
K.K. Jain, CEO, Jain PharmaBiotech
Proteomic Signatures of the Ubiquitin/Proteasome Pathway
Matthew Kuruc, President and COO, ProFACT Proteomics
Population Proteomics: The Concept, Attributes and Potential for Cancer Biomarker Research
Dobrin Nedelkov, Senior Scientist, Intrinsic Bioprobes
Cancer Biomarkers and Their Increasing Importance in the Clinical Management of Disease
Peter Schulz-Knapp, CSO, Proteome Sciences
Immune Response and Biomarker Profiling Using Human Protein Microarrays
Michael Smith, Scientist, Invitrogen
Panels of Tumor Antigen Binding to Serum IgGs in Cancer Patients
Michael Tainsky, Professor, Wayne State University School of Medicine/ Karmanos Cancer Institute
Peptidomics - Technologies for Discovery of Low Molecular Weight Cancer Biomarkers
Harald Tammen, Medical Research, Digilab BioVision
|
|
|